4//SEC Filing
Gupta Rishi 4
Accession 0001209191-23-053004
CIK 0001764974other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:40 PM ET
Size
6.1 KB
Accession
0001209191-23-053004
Insider Transaction Report
Form 4
Gupta Rishi
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-16+25,540→ 25,540 totalExercise: $2.61Exp: 2033-10-15→ Common Stock (25,540 underlying)
Footnotes (2)
- [F1]Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the date of the first annual general meeting of stockholders occurring after October 12, 2023, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]Pursuant to an agreement between OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefits thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP.
Documents
Issuer
Turnstone Biologics Corp.
CIK 0001764974
Entity typeother
Related Parties
1- filerCIK 0001537370
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 6:40 PM ET
- Size
- 6.1 KB